The cost-effectiveness of losartan in type 2 diabetics with nephropathy in Switzerland - an analysis of the RENAAL study

The cost-effectiveness of losartan in type 2 diabetics with nephropathy in Switzerland - an analysis of the RENAAL study

Bibliographic Details
Main Authors:	MS Sandoz, GW Keusch
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2004-08-01
Series:	Swiss Medical Weekly
Subjects:	Switzerland Nephropathy Diabetes cost effectiveness Losartan
Online Access:	https://www.smw.ch/index.php/smw/article/view/399

Similar Items

The Effect of Crocin and Losartan on Biochemical Parameters and Oxidative Stress Markers in Diabetic Nephropathy Rats Model
by: Yaser Mohammadi, et al.
Published: (2022-07-01)

The effect of crocin and losartan on TGF-β gene expression and histopathology of kidney tissue in a rat model of diabetic nephropathy
by: Yaser Mohammadi, et al.
Published: (2023-03-01)

Tetrahydrocurcumin Add‐On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury
by: Mahyar Khazaeli, et al.
Published: (2023-04-01)

Prevalence and direct medical costs of end-stage renal disease in patients with type 2 diabetes mellitus in Switzerland for 2001
by: SM Ess
Published: (2004-08-01)

Determination of Losartan and Losartan Carboxylic acid in Human Plasma by New HPLC Method with Fluorescence Detection for Pharmacokinetics Studies
by: Ahmed Abbas Hussein
Published: (2014-12-01)

Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan
by: Jin Seong Hyeon, et al.
Published: (2020-11-01)

Effect of Crocin and Losartan on Insulin Resistance and Protecting Pancreatic Tissue in Streptozotocin-Induced Diabetic Rats
by: Yaser Mohammadi, et al.
Published: (2022-11-01)

Cost of dementia in Switzerland
by: E Kraft, et al.
Published: (2010-08-01)

Antihypertensive and antihyperglycemic effects of combinations of losartan with metformin and/or glibenclamide in desoxycorticosterone acetate and streptozotocin-induced hypertensive diabetic rats
by: Emuesiri Goodies Moke, et al.
Published: (2023-04-01)

INFLUENCE OF N-ACETYLCYSTEINE AND LOSARTAN ON THE EARLY ELECTROCARDIOGRAPHIC CHANGES IN RATS WITH STREPTOZOTOCIN TYPE 1 DIABETES MELLITUS
by: I. Sytnyk, et al.
Published: (2016-09-01)

Losartan and QT Dispersion in Hypertensive Patients on Maintenance Hemodialysis
by: Alparslan Ersoy, et al.
Published: (2014-12-01)

Efficacy and safety of losartan in childhood immunoglobulin A nephropathy: a prospective multicenter study
by: Hyesun Hyun, et al.
Published: (2023-12-01)

Mimosa pudica mucilage nanoparticles of losartan potassium: Characterization and pharmacodynamics evaluation
by: Shazia Akram Ghumman, et al.
Published: (2023-08-01)

Comparison of Anti Hypertensive Effect of Fixed Dose Enalapril and Losartan in Essential Hypertension
by: Khurram Mansoor
Published: (2009-06-01)

INFLUENCE OF N-ACETYLCYSTEINE AND LOSARTAN ON MODULATION OF CYTOPROTECTIVE AUTOPHAGY IN MYOCARDIUM OF RATS WITH EXPERIMENTAL TYPE 1 DIABETES MELLITUS (FOR ELECTRONIC MICROSCOPY EXPLANATION)
by: I.M. Sytnyk, et al.
Published: (2017-09-01)

Switzerland through the eyes of others /
by: Coordinating Committee for the Presence of Switzerland Abroad
Published: (1992)

Development and evaluation of sustained release losartan potassium matrix tablet using kollidon SR as release retardant
by: Shahid Sarwar, et al.
Published: (2012-12-01)

Estimation of cost-of-illness in patients with psoriasis in Switzerland
by: AA Navarini, et al.
Published: (2010-02-01)

Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus
by: T. Yu. Poniatowskaya
Published: (2015-03-01)

An Overview of Diabetic Nephropathy
by: Alp Atasoy, et al.
Published: (2015-03-01)

Morphological pattern of non-diabetic nephropathy in type 2 diabetes mellitus patients
by: Meral Mese, et al.
Published: (2022-06-01)

Cost impact of blood glucose self-monitoring on complications of type 2 diabetes: a Swiss perspective (ROSSO study No.11)
by: B Schneider, et al.
Published: (2007-10-01)

Comparison of the GPVI inhibitors losartan and honokiol
by: Marie-Blanche Onselaer, et al.
Published: (2020-02-01)

Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial
by: Noelle Castilla‐Ojo, et al.
Published: (2023-10-01)

Economic evaluation of bailing capsules for patients with diabetic nephropathy in China
by: Yumei He, et al.
Published: (2023-07-01)

Hypoglycemia in Patients with Type-2 Diabetes Mellitus Nephropathy
by: Faheem Ur Rahman, et al.
Published: (2023-06-01)

The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010
by: Andreas Maercker, et al.
Published: (2012-12-01)

Switzerland an inside view : politics, economy, culture, society, nature /
by: Coordinating Committee for the Presence of Switzerland Abroad
Published: (1992)

The Frequency of Diabetic Nephropathy in Children and Adolescents with Type 1 Diabetes Mellitus
by: Neda Mostofizadeh, et al.
Published: (2019-09-01)

Switzerland /
by: Flueler, Niklaus, et al.
Published: (1985)

Asprosin in early detection of nephropathy in type2 diabetes mellitus
by: Ola Hussein Abed Alwahid, et al.
Published: (2023-01-01)

The Protective Effect of Garlic Extract on Diabetic Nephropathy
by: Mahmoud Rafieian-Kopaei, et al.
Published: (2013-10-01)

Losartan Reduces Remodeling and Apoptosis in an Adriamycin-Induced Cardiomyopathy Rat Model
by: Hyeon A Kim, et al.
Published: (2023-09-01)

Editorial: Association between diabetic nephropathy and diabetic retinopathy or non-diabetic nephropathy
by: Haiyong Chen, et al.
Published: (2024-01-01)

COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO
by: Akhmad Kharis Nugroho, et al.
Published: (2014-01-01)

Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China
by: Wanyi Xu, et al.
Published: (2023-04-01)

Frequency of Hyperuricemia in Type-2 Diabetes Mellites and its Relation with Diabetic Nephropathy
by: Gulzar Ali, et al.
Published: (2023-02-01)

Determining the Effects of Morphine, Heroin, and Losartan and the Interaction of each on Losartan in Water Homeostasis Mechanisms by the Kidney in Adult Male Rabbits
by: F Foroohi, et al.
Published: (2015-04-01)

Losartan Alleviates the Side Effects and Maintains the Anticancer Activity of Axitinib
by: Ying Fu, et al.
Published: (2022-04-01)

Cost of disorders of the brain in Switzerland wth a focus on mental disorders
by: P Sobocki
Published: (2008-01-01)